Final Results For The 1703 Phase 1b/2 Study Of Elotuzumab In Combination With Lenalidomide And Dexamethasone In Patients With Relapsed/Refractory Multiple MyelomaPaul G. Richardson,Sundar Jagannath,Philippe Moreau,Andrzej J. Jakubowiak,Marc S. Raab,Thierry Facon,Ravi Vij,Darrell White,Donna E. Reece,Lotfi Benboubker,Jeffrey Zonder,L. Claire Tsao,Kenneth C. Anderson,Eric Bleickardt,Anil K. Singhal,Sagar LonialBLOOD（2014）引用 44|浏览13暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
